Huw Jones
CEO, Chronos Therapeutics


Huw has been CEO of Chronos Therapeutics in Oxford since 2013.

In that time he has extracted the company from Oxford University, raised substantial grant and equity finance and led Chronos’ acquisition of three early research programmes in brain disease from Shire PLC.

He was surprised and pleased to have been awarded European CEO of the year 2016 for drug discovery by European CEO
Magazine, alongside leaders in their sectors from Adidas, Unilever and Spotify.

Previous posts include: NED, then rescue CEO, Ardana PLC; non–executive chairman, Ashbourne Pharmaceuticals; president Europe, CV Therapeutics Inc; SVP, Elan Pharmaceuticals and various roles of increasing responsibility at SmithKline Beecham (GSK).

In his varied career he has launched dozens of new medicines in several countries, completed tens of M&A transactions and managed many drug development programmes. Huw holds a PhD in neuropharmacology from the University of Birmingham, he is a passionate SCUBA diver and wine lover but never combines the two.
Processing. Please wait.